SAVA

Cassava Sciences, Inc.

19.65 USD
-0.15 (-0.76%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cassava Sciences, Inc. stock is down -9.32% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.83% of the previous 23 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Jun 14:04 17 Jan, 2025 10.00 PUT 486 2255
12 Jun 16:03 20 Jun, 2025 30.00 CALL 32 104
14 Jun 16:29 17 Jan, 2025 10.00 PUT 196 2785
17 Jun 15:28 16 Jan, 2026 15.00 CALL 35 136
17 Jun 19:43 17 Jan, 2025 10.00 PUT 250 2978
17 Jun 19:44 17 Jan, 2025 10.00 PUT 176 2978
21 Jun 15:13 21 Jun, 2024 22.00 PUT 200 248
21 Jun 15:45 12 Jul, 2024 22.00 PUT 102 2
21 Jun 19:47 21 Feb, 2025 10.00 PUT 117 0
21 Jun 19:47 21 Feb, 2025 10.00 PUT 144 0

About Cassava Sciences, Inc.

Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial.